Carl Icahn
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
View Older Stories View More Recent Stories
-
ImClone Systems (IMCL) Chairman Carl Icahn Sends Letter to Bristol-Myers
-
Amylin Pharma (AMLN) Higher After Icahn Boosts Stake
-
Icahn Says $70/Share Isn't Adequate for ImClone (IMCL) -DJ
-
Unusual 11 Mid-Day Movers 9/10: ACBA, AVAV, STLD, RBN Higher; ENCO, DTG, GFIG, WM Lower
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
Notable Mergers and Acquisitions of the Day 9/10: IMCL/BMY, VSH/IRF, MSFT/SRVY
-
ImClone (IMCL) Tells Bristol-Myers (BMY) $60/Sh Offer Is Inadequate; Says $70/Sh Offer On the Table From Another
-
Icahn Down $60M on Healthcare Stocks This Week (AMLN, BIIB, CYBX, REGN, FOLD)
-
Amylin Pharm (AMLN) Sinks On Byetta Pancreatitis Cases; Smart Money May Be Moving In
-
Icahn's Icahn Capital Bumps Stake in Motorola (MOT), Shows New Small Stake in Emisphere (EMIS)
-
Carl Icahn's 13F Is Out
-
Icahn Boosts Stake in Biogen Idec (BIIB) to 6% Following TYSABRI Sell-Off
-
Enzon Pharma (ENZN) To Explore Options for Specialty Pharmaceuticals Business
-
WCI Communities (WCI) Files Chapter 11; Starkey Out As CEO
-
ImClone (IMCL) Said Bristol-Myers' (BMY) Offer Substantially Undervalues The Company
-
StreetInsider.com Top 10 News Items 7/28-8/1: Merrill, ImClone, Biogen/Elan, More...
-
Citi Downgrades Imclone Systems (IMCL) to Hold
-
Icahn Has A Happy Day, Racks Up Gains of At Least $350M
-
Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
-
Notable Mergers and Acquisitions of the Day 7/31 (IMCL/BMY, GM, GG)
-
Pre-Open Movers 7/31: Imclone (IMCL) Surges On Takeover Offer; Akamai (AKAM) Sinks On Results/Guidance
-
Amylin Pharmaceuticals (AMLN) Could Be One To Watch On ImClone Bid
-
Biogen Idec (BIIB) Could Be One To Watch On ImClone Bid
-
Bristol-Myers (BMY) Offers $60/Share for ImClone (IMCL) In Letter To Icahn
-
Second Quarter GDP Release Set to Confirm or Deny U.S. Recessionary Fears
-
Top 10 News Items for the Week of July 21-25: American Express (AXP), Bank of America (BAC), Costco (COST), More...
-
Details of Yahoo (YHOO) And Carl Icahn Agreement; Must Maintain Ownership of 30M Shares
-
Pre-Open Movers 7/21: Genentech (DNA) Higher on Bid for Roche; BofA (BAC) Up on Results
-
Yahoo! (YHOO) Down 2% Following Icahn Settlement News
-
Yahoo! (YHOO) And Carl Icahn Announces Settlement; Icahn Appointed, Two Others Nominated
-
Yahoo (YHOO) announces settlement with Carl Icahn
-
Legg Mason (LM) Supports Yahoo! (YHOO) Directors
-
Icahn Lowers Stake in Greenbrier (GBX) to 6.77%
-
Microsoft (MSFT) Comments on Discussions Involving Yahoo (YHOO) and Carl Icahn
-
Details of Offer Made By Microsoft (MSFT) To Yahoo (YHOO) On Friday
-
Notable Mergers and Acquisitions of the Day 7/14 (BUD, YHOO/MSFT, WMI/RSG)
-
Pre-Open Movers 7/14: Fannie (FNM), Freddie (FRE) Up On U.S. Back-Stop Plan; Republic Services (RSG) Up on Waste Management Offer
-
Yahoo! (YHOO) Rejects Latest Proposal from Microsoft/Icahn
-
Yahoo! (YHOO) Statement in Response to Carl Icahn's Latest Open Letter
-
Yahoo! (YHOO) Jumps 9% After Microsoft Said It Would Be Open To Talks With a New Board
-
Notable Mergers and Acquisitions of the Day 7/7 (YHOO/MSFT, MER/BLK, GE, KWK)
-
Microsoft (MSFT) Issues Statement Regarding The Carl Icahn Letter
-
Icahn Issues Open Letter to Yahoo! (YHOO); Talked With Balmer Who Would Be Interested In Talks With a New Board
-
Lear (LEA) volatility Spikes as share sell off on downgrade
-
Icahn Boosts Stake in Yahoo! (YHOO) to 4.98%
-
Icahn In Talks With WCI Communities' (WCI) Special Committee
-
Carl Icahn Opens His Blog, The Icahn Report, to the Public
-
Carl Icahn Loses Proxy Battle At Biogen Idec (BIIB)-WSJ
-
Deutsche Bank Starts Biogen-IDEC (BIIB) at Hold
-
Carl Icahn & Friends Whiff On Yahoo (YHOO)
